Crossmark

Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow transplantation with post-transplantation cyclophosphamide

Crossref DOI link: https://doi.org/10.1038/s41409-024-02299-y

Published Online: 2024-05-07

Published Print: 2024-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sinanidis, Ilias

Hochman, Michael J.

Tsai, Hua-Ling

Randall, Michael P.

Bonilla, Brandon

Varadhan, Ravi

Ambinder, Alexander J. https://orcid.org/0000-0003-0855-9653
Jones, Richard J.

DeZern, Amy E. https://orcid.org/0000-0001-5225-4609
Karantanos, Theodoros https://orcid.org/0000-0002-6792-8298
License Information

Text and Data Mining valid from 2024-05-07

Version of Record valid from 2024-05-07
More Information

Article History

Received: 14 April 2024

Revised: 22 April 2024

Accepted: 25 April 2024

First Online: 7 May 2024

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below